Perimeter Medical Imaging AI Closes C$3.6 Million Non-Brokered Private Placement

Core Viewpoint - Perimeter Medical Imaging AI, Inc. has successfully closed a non-brokered private placement, raising C$3,556,315 to accelerate the commercialization of its S-Series device and strengthen its balance sheet ahead of the anticipated FDA decision for the B-Series in the first half of 2026 [1][2]. Group 1: Financing Details - The company issued a total of 19,757,306 Units at a price of C$0.18 per Unit, with each Unit consisting of one common share and one warrant [1]. - The warrants allow holders to purchase additional common shares at an exercise price of C$0.35 for a period of 60 months [1]. - The net proceeds from the financing will be used for technology commercialization, product development, and general corporate purposes [4]. Group 2: Commercialization Strategy - The S-Series device is gaining traction in hospitals, with increasing utilization among surgeons, which is expected to drive demand for the upcoming B-Series [2]. - The company is on track for a regulatory decision on the AI-powered B-Series in the first half of 2026, which is viewed as a significant growth opportunity [2]. - The CEO emphasized the importance of this financing round in supporting the company's commercial strategy and establishing its imaging solutions as a transformative technology in surgical care [2][3]. Group 3: Insider Participation - CEO Adrian Mendes purchased 11,656,642 Units in the Offering, reflecting his confidence in the company's growth trajectory [6]. - Insider Mr. Schiralli acquired 1,111,111 Units, indicating strong support from current shareholders [8]. - The participation of insiders in the Offering is classified as a "related party transaction," and the company has relied on exemptions from formal valuation and minority shareholder approval requirements [6].